Understanding pharmaceutical polymorphic transformations I: influence of process variables and storage conditions.

about

Understanding pharmaceutical polymorphic transformations II: crystallization variables and influence on dosage forms.Identification of Polymorphic Forms of Active Pharmaceutical Ingredient in Low-Concentration Dry Powder Formulations by Synchrotron X-Ray Powder Diffraction

P2860

Q38543393-BDE611A4-FF79-4808-8E0E-8CB086F116AC Q42370961-0FCB4B7C-4F9F-4AC3-AB62-5E3E25684C5F

P2860

Understanding pharmaceutical polymorphic transformations I: influence of process variables and storage conditions.

Item

http://www.wikidata.org/entity/Q38270691

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Understanding pharmaceutical p ...... iables and storage conditions.

@en

type

Item

label

Understanding pharmaceutical p ...... iables and storage conditions.

@en

prefLabel

Understanding pharmaceutical p ...... iables and storage conditions.

@en

P1476

Understanding pharmaceutical p ...... iables and storage conditions.

@en

P2093

Ashok K Tiwary

http://www.w3.org/2001/XMLSchema#string

Bharti Sapra

http://www.w3.org/2001/XMLSchema#string

Jatin Sood

http://www.w3.org/2001/XMLSchema#string

Manish Jindal

http://www.w3.org/2001/XMLSchema#string

Sameer Bhandari

http://www.w3.org/2001/XMLSchema#string

P2860

A new tetrahydrated form of sodium naproxen.

Fast surface crystallization of amorphous griseofulvin below T g.

Influence of microenvironment pH, humidity, and temperature on the stability of polymorphic and amorphous forms of clopidogrel bisulfate.

Polymorphs and hydrates of acyclovir

Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes.

A kinetic study of the polymorphic transformation of nimodipine and indomethacin during high shear granulation.

Characterisation of ilomastat for prolonged ocular drug release

Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.

Pharmaceutical applications of hot-melt extrusion: part I.

Influence of polyethylene glycol/polyethylene oxide on the release characteristics of sustained-release ethylcellulose mini-matrices produced by hot-melt extrusion: in vitro and in vivo evaluations.

P304

1123-1142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/TDE.14.68

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268788740

http://www.w3.org/2001/XMLSchema#string

P698

25418270

http://www.w3.org/2001/XMLSchema#string

Understanding pharmaceutical polymorphic transformations I: influence of process variables and storage conditions.

about

P2860

P2860

Understanding pharmaceutical polymorphic transformations I: influence of process variables and storage conditions.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698